SEPS Pharma provides advanced drug product development services to the leading pharmaceutical and biotechnology companies. SEPS Pharma is dedicated to the development of innovative drug delivery systems and novel prodrug approaches serving solutions to enhance bioavailability and control drug release.
SEPS Pharma offers a full suite of drug development services encompassing preclinical development, preformulation development, formulation development, dosage forms development and scaling-up of small molecules and biopharmaceuticals for oral, pulmonary, nasal and parenteral delivery.
SEPS Pharma’s HighWay-to-ClinicTM program covers the development of liquid formulations for oral and parenteral delivery supporting preclinical and early human studies. The program encloses a quick screening and evaluation of multiple formulation concepts and their chemical and physical stability:
• Aqueous solutions/solutions in pharmaceutical acceptable organic solvent(s)
• Aqueous microsuspensions
• Aqueous nanosuspensions
SEPS Pharma is specialized in drug product development of poorly soluble drug candidates applying:
• Nanoformulations
• Amorphous solid dispersion via spray drying, bead coating and hot-melt extrusion
• Self emulsifying drug delivery systems
Specialties
Drug product development, Oral delivery, Parenteral delivery, Pulmonary delivery, Nasal delivery, Solid dispersions, Nanoformulations
